bms-650032 and Psoriasis

bms-650032 has been researched along with Psoriasis* in 1 studies

Other Studies

1 other study(ies) available for bms-650032 and Psoriasis

Article	Year
Case of psoriatic patient who maintains long-term remission after anti-hepatitis C virus agents and ustekinumab treatment. The Journal of dermatology, 2018, Volume: 45, Issue:3 Topics: Aged; Antiviral Agents; Carbamates; Dermatologic Agents; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Isoquinolines; Male; Psoriasis; Pyrrolidines; Remission Induction; RNA, Viral; Severity of Illness Index; Sulfonamides; Ustekinumab; Valine	2018

Article

Year

Case of psoriatic patient who maintains long-term remission after anti-hepatitis C virus agents and ustekinumab treatment.

The Journal of dermatology, 2018, Volume: 45, Issue:3

Topics: Aged; Antiviral Agents; Carbamates; Dermatologic Agents; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Isoquinolines; Male; Psoriasis; Pyrrolidines; Remission Induction; RNA, Viral; Severity of Illness Index; Sulfonamides; Ustekinumab; Valine

2018